GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Net Margin %

Actelion (XSWX:ATLNE) Net Margin % : 30.48% (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Actelion's Net Income for the three months ended in Mar. 2017 was CHF197 Mil. Actelion's Revenue for the three months ended in Mar. 2017 was CHF646 Mil. Therefore, Actelion's net margin for the quarter that ended in Mar. 2017 was 30.48%.

The historical rank and industry rank for Actelion's Net Margin % or its related term are showing as below:

XSWX:ATLNE' s Net Margin % Range Over the Past 10 Years
Min: -8.15   Med: 20.51   Max: 30.33
Current: 28.89


XSWX:ATLNE's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -160.92 vs XSWX:ATLNE: 28.89

Actelion Net Margin % Historical Data

The historical data trend for Actelion's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Net Margin % Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.54 25.34 30.33 26.98 28.80

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.25 30.91 36.09 18.35 30.48

Competitive Comparison of Actelion's Net Margin %

For the Biotechnology subindustry, Actelion's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actelion's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Net Margin % distribution charts can be found below:

* The bar in red indicates where Actelion's Net Margin % falls into.



Actelion Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Actelion's Net Margin for the fiscal year that ended in Dec. 2016 is calculated as

Net Margin=Net Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=696.386/2417.938
=28.80 %

Actelion's Net Margin for the quarter that ended in Mar. 2017 is calculated as

Net Margin=Net Income (Q: Mar. 2017 )/Revenue (Q: Mar. 2017 )
=196.957/646.253
=30.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion  (XSWX:ATLNE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Actelion Net Margin % Related Terms

Thank you for viewing the detailed overview of Actelion's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (XSWX:ATLNE) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines